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miR-US5-2Human cytomegalovirus (HCMV) miRNAs are important for regulation of viral infection and evasion of host
immune responses. Unfortunately, the importance of HCMV miRNAs cannot be addressed in vivo due to the
species speciﬁcity of CMVs. Rhesus CMV (RhCMV) infection of rhesus macaques provides an important model
system for HCMV pathogenesis due to the genetic similarity between the viruses. In this report, seventeen
RhCMV miRNAs were identiﬁed using Next Generation Sequencing. In ﬁbroblasts, RhCMV miRNAs associate
with Argonaute proteins and display several patterns of expression, including an early peak in expression fol-
lowed by decline and accumulation throughout infection. Additionally, RhCMV encodes an HCMV miR-US5-2
homologue that targets the 3′ UTR of RhCMV US7. Finally, examination of salivary gland tissue from infected
animals revealed the presence of a subset of viral miRNAs. This study highlights the importance of the RhCMV
model system for evaluating the roles of CMV miRNAs during viral infection.
© 2012 Elsevier Inc. All rights reserved.Introduction
Human cytomegalovirus (HCMV) is an ubiquitous pathogen that
causes persistent, but clinically benign, infections in healthy individ-
uals. Severe disease can occur in immunocompromised patients such
as organ transplant recipients or individuals co-infected with HIV
(Clarke et al., 1996; Rowshani et al., 2005). In addition, HCMV is
the leading congenitally-transmitted viral infection (Pereira et al.,
2005). Animal models play a crucial role in understanding host/
pathogen interactions, but studies of HCMV pathogenicity and im-
mune evasion have been hampered due to the strict species speciﬁc-
ity of CMVs (McGeoch et al., 2000). Although rodent CMVs are useful
models for virus infection, these viruses share limited genetic ho-
mology with HCMV, especially in genes non-essential for growth in
tissue culture (McGeoch et al., 1995; Rawlinson, Farrell and Barrell,
1996; Vink et al., 2000). In contrast, rhesus CMV (RhCMV), which
is ubiquitous in rhesus macaque (Macaca mulatta) colonies, has exten-
sive homology with HCMV at the genome level (Baskin, 1987; Hansen
et al., 2003; Kuhn et al., 1999; Lockridge et al., 1999; Pitcher et al.,
2002; Vogel et al., 1994). Most RhCMV infections are asymptomatic,
but in immunocompromised animals the virus causes similar patternsInstitute, Oregon Health & Sci-
97006, USA. Fax: +1 503 494
logy, University of Wisconsin,
rights reserved.of infection and pathology and exhibits humoral and cellular immune
responses closely matching those of HCMV (Baskin, 1987; Kaur et al.,
2003; Kuhn et al., 1999; Lockridge et al., 1999; Picker et al., 2004;
Pitcher et al., 2002; Price et al., 2008). Thus, infection of rhesus ma-
caqueswith RhCMV allows for the study of CMVpathogenicity, immune
evasion and persistence in a relevant non-human primate system.
MicroRNAs (miRNAs) are a class of ~22 nucleotide (nt) non-
coding RNAs involved in post-transcriptional regulation of target
genes. pri-miRNAs are capped and polyadenylated transcripts which
can contain one or several ~80nt hairpins that are further processed
by the cell to form mature miRNAs (Cai et al., 2004). These hairpins
are cleaved ﬁrst in the nucleus by the RNase III enzyme Drosha to pro-
duce a ~60nt pre-miRNA, and then transported to the cytoplasm by
Exportin5 (Yi et al., 2003). The pre-miRNA hairpin is further pro-
cessed by a second RNase III enzyme Dicer, which releases the
double-stranded miRNA (Hutvagner et al., 2001; Lee et al., 2002). A
single strand of the mature miRNA is incorporated into the multi-
protein RNA-induced silencing complex (RISC) that associates with
the target mRNAs, usually within the mRNA 3′ untranslated region
(UTR) (Hammond et al., 2000). This interaction results in gene silenc-
ing through either mRNA degradation or translational repression
(Bartel, 2009; Guo et al., 2010; Lim et al., 2005). miRNAs are found
in most multicellular eukaryotes and play important regulatory
roles in many cellular processes, including development, apoptosis
and cancer (Farazi et al., 2010; Lima et al., 2011; Tiscornia and
Izpisua Belmonte, 2011). DNA viruses, mostly of the Herpesvirus fam-
ily, also encode miRNAs. To date, over 230 viral miRNAs have been
identiﬁed (Grundhoff and Sullivan, 2011; Tuddenham and Pfeffer,
Table 2
Distribution of small RNAs from RhCMV-infected rhesus ﬁbroblasts.
# of
sequences
% of
sequences
# of unique
sequences
% of unique
sequences
Raw 14,186,475 100 790,102 100
Mappable 13,068,450 92.12 40,665 5.15
Mapped (Total) 10,773,233 75.94 16,439 2.08
Unmapped (Total) 2,307,330 16.26 25,063 3.17
Mapped to RhCMV genome 44,949 0.32 190 0.02
134 M.H. Hancock et al. / Virology 425 (2012) 133–1422011). HCMV encodes at least 14miRNAs (Grey et al., 2005; Pfeffer et al.,
2004) several of which target cellular genes involved in cell cycle regula-
tion and the immune response to viral infection (Grey et al., 2010; Stern-
Ginossar et al., 2007). In addition, some HCMV miRNAs also target viral
genes (Grey et al., 2007; Murphy et al., 2008; Stern-Ginossar et al.,
2009; Tirabassi et al., 2011), which could be important for limiting viral
gene expression during persistence, latency and/or during reactivation.
miRNAs are non-immunogenic, and as such may be an excellent
mechanism to modulate host and viral gene expression in situations of
viral latency. Unfortunately, these hypotheses are difﬁcult to address for
HCMV due to the lack of a relevant model system.
While the miRNAs encoded by HCMV, mouse CMV (MCMV) and
rat CMV (RCMV) have been reported (Buck et al., 2007; Dolken
et al., 2007; Grey et al., 2005; Meyer et al., 2011; Pfeffer et al., 2004),
the identiﬁcation and expression of RhCMV miRNAs are unknown.
In this study we examined the expression of RhCMV miRNAs in rhe-
sus ﬁbroblasts, endothelial cells and tissues. We found that RhCMV
encodes multiple miRNAs with different abundance and kinetics of
expression as well as a positional and functional homologue of an
HCMV miRNA. These studies provide the basis for examining the
role of CMV miRNAs during pathogenesis and persistence in a rele-
vant non-human primate model system.
Results
RhCMV encodes multiple miRNAs that are clustered in distinct regions of
the viral genome
To identify RhCMV-encoded miRNAs, RNA isolated from virus-
infected ﬁbroblasts at three day post infection (dpi) was analyzed
by Next Generation Sequencing (NGS). A total of 14,186,475 reads
were made from the RhCMV-infected ﬁbroblasts, with over 75% of
the sequences mapping to miRBase (Table 2). 88.9% of these se-
quences were within 20 to 24 nucleotides in length. Of the
2,307,330 unmapped sequences, 44,949 (0.02%) mapped to hair-
pin structures within the RhCMV genome. The remainder of the
unmapped sequences likely represent non-coding RNAs, unrecog-
nized rhesus macaque miRNAs or RNA degradation products.
Seventeen potential RhCMVmiRNAs were identiﬁed by NGS based
on sequence length, copy number, mapping to the RhCMV genome
and formation of stable hairpins. Consistent with standard nomencla-
ture, the miRNAs are identiﬁed according to the closest open reading
frame on the same strand. The viral miRNAs ranged in size from 18 to
23 nucleotides and were detected at copy numbers from 3 to 42705.Table 1
miRNA RT-PCR primer and probe sets.
Target RT primera Taqman forward primer Probe
miR-Rh04 TCACCA GCGGTCCTTTGTATA TGGATACGACTCACCA
miR-Rh16 CTAGAG GCGCTGGGACCGAGTAGCT TGGATACGACCTAGAG
miR-Rh70 CACTGC GCGGGACGCATCTGGGAGCT TGGATACGACCACTGC
miR-Rh94 CACGGC GCGCTGGCGACCTGGGCAT TGGATACGACCACGGC
miR-Rh96-1 CGCCTG GCGGGCAGTGCTGGATCGGG TGGATACGACCGCCTG
miR-Rh96-2 TGGCAT GCGGAAGGCCGGCTTCTCGG TGGATACGACTGGCAT
miR-Rh96-3 AAGAGG GCGGCGGGCCAACCTAGC TGGATACGACAAGAGG
miR-Rh106-1 ACGACC GCGGAACTCTCGGATGAGGT TGGATACGACACGACC
miR-Rh106-2 ATGCTG GCGGACTTGTGGTTTCTGG TGGATACGACATGCTG
miR-Rh156-1 CATGAG GCGGATATGGCGTCTATGG TGGATACGACCATGAG
miR-Rh156-2 GGCCAC GCGGCATTGACGTCAATGG TGGATACGACGGCCAC
miR-Rh157 AGTCCA GCGGTTCAATATGGCGTTT TGGATACGACAGTCCA
miR-Rh159 ACAACC GCGGTGCCTTATGGTCGTT TGGATACGACACAACC
miR-Rh176 ACGCGG GCGGTAGGCCCTCTCTACC TGGATACGACACGCGG
miR-Rh183-1 GATTTC GCGCTTTATGATCGGTGCGA TGGATACGACGATTTC
miR-Rh183-2 CACACC GCGGGACGGTCAACGGTA TGGATACGACCACACC
miR-Rh225 TCTCCA GCGGTCCGGAACGGGAGAC TGGATACGACTCTCCA
a All RT primers share the sequence GTCGTATCCAGTGCAGGGTCCGAGGTATTCG-
CACTGGATACGAC, with the last six unique 3′ nucleotides listed in the table.Secondary structure predictions (LC Sciences, (Zuker, 2003)) demon-
strate that the potential RhCMV miRNAs could fold into the hairpin
structures typical of pre-miRNAs (Fig. 1). Table 3 shows the predom-
inant consensus sequence for eachmiRNA. Variability in the 3′ ends of
the miRNAs was common, whereas any sequences detected with var-
iability in the 5′ end for each miRNA were only a minor species (data
not shown). Similar 3′ and 5′ variability has been noted with many
other herpesviruses (Amen and Grifﬁths, 2011; Meyer et al., 2011;
Riley et al., 2010; Zhu et al., 2010).
The genomic locations of the 17 RhCMV miRNAs are depicted
in Fig. 2. Similar to HCMV, the RhCMV miRNAs are generally dis-
tributed across the viral genome with major clusters in two re-
gions. One cluster of three miRNAs is located near the IE region
of the genome (encoded by the Rh156 exons) and includes miR-
Rh156-1, miR-Rh156-2 and miR-Rh157. Intriguingly, similar to
the rodent CMVs, a second cluster exists either close to or within
the viral origin of replication (nucleotides 88161 to 90525
(Hansen et al., 2003)) including miR-Rh94, miR-Rh96-1, miR-
Rh96-2 and miR-Rh96-3. Although these miRNAs are clustered,
each miRNA is encoded within their own hairpin structure
(Fig. 1). Comparison of the miRNA sequences of HCMV and
RhCMV did not reveal signiﬁcant sequence homology between
the miRNAs of these viruses, with the exception of miR-Rh183-1
which is a positional homologue of HCMV miR-US5-2 and encodes
a similar seed sequence (see below).RhCMV miRNAs are differentially expressed in cells
To conﬁrm the expression of RhCMV miRNAs during infection, we
designed primer and probe sets for miRNA-speciﬁc, stem-loop real
time PCR for 16 of the 17 predicted miRNAs. Using this technique, we
were able to detect 13 rhesus-speciﬁc miRNAs. We were not able to
reliably detect miR-Rh156-1, miR-Rh157 and miR-Rh-159. The miR-
Rh156-1 assay detected product in themock samples at levels compara-
ble to infected cells, suggesting the presence of a cellular product with
similar 3′ sequence (stem-loop primers are designed based on the 3′
sequence for each miRNA). Additionally, two of the viral miRNAs
identiﬁed by deep sequencing, miR-Rh157 and miR-Rh159, were
detected at copy numbers below the reliable limit of detection by the
Real-time PCR assay. We were unable to successfully design an assay
to detectmiR-Rh04, whichmay be due to the shorter size of themiRNA.
Expression of each RhCMV miRNA was examined over a time-
course of infection to determine their temporal expression
patterns. In ﬁbroblasts, HCMV miRNAs are undetectable at very
early times in infection but increase in abundance throughout
infection (Grey et al., 2005; Murphy et al., 2008). In contrast,
RhCMV miRNAs display three distinct expression patterns
(Fig. 3). The ﬁrst pattern of expression is similar to that observed for
HCMVmiRNAs,wheremiR-Rh16,miR-Rh176 andmiR-Rh183-1 accumu-
lated to high copy number over the 120 hour time-course. Similarly, miR-
Rh96-1, miR-Rh156-2 and miR-Rh225 also accumulated, but were much
less abundant. The second pattern of expression is exempliﬁed by miR-
Rh70, miR-Rh96-2, miR-Rh96-3, miR-Rh106-1and miR-Rh183-2 where
copy number per cell peaked between 24 and 48 h followed by a
considerable decline in miRNA copy number. Finally, miR-Rh106-2
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Fig. 1. RhCMV pre-miRNA stem-loop structures. Stem-loop structures were predicted using the mfold program (Zuker, 2003). Mature miRNA sequences are highlighted in gray and
depicted in capitalized letters.
Table 3
RhCMV miRNAs identiﬁed from infected rhesus ﬁbroblasts.
miRNA Sequence Length Copy number of isoform Copy number of all isoforms Strand Starta
miR-Rh04 TCCTTTGTATAGTGGTGA 18 3 3 − 3278
miR-Rh16 TGGGACCGAGTAGCTACTCTAG 22 18253 42705 − 13078
miR-Rh70 GACGCATCTGGGAGCTAGCAGTG 23 6 15 − 55945
miR-Rh94 TGGCGACCTGGGCATAGCCGTG 22 3 3 + 87960
miR-Rh96-1 GCAGTGCTGGATCGGGACAGGCG 23 3 3 + 88610
miR-Rh96-2 AAGGCCGGCTTCTCGGGATGCCA 23 3 3 + 89430
miR-Rh96-3 CGGGCCAACCTAGCGCCTCTT 21 17 49 + 89771
miR-Rh106-1 AACTCTCGGATGAGGTGGGTCGT 23 3 3 + 102704
miR-Rh106-2 ACTTGTGGTTTCTGGGCAGCAT 22 83 200 + 103662
miR-Rh156-1 ATATGGCGTCTATGGACTCATG 22 8 16 − 162033
miR-Rh156-2 CATTGACGTCAATGGGGTGGCC 22 9 29 − 161426
miR-Rh157 TTCAATATGGCGTTTATGGACT 22 3 3 + 162076
miR-Rh159 TGCCTTATGGTCGTTTGGTTGT 22 4 4 + 164314
miR-Rh176 TAGGCCCTCTCTACCCCCGCGT 22 13 16 − 180692
miR-Rh183-1 TTTATGATCGGTGCGACGAAATC 23 366 842 + 187856
miR-Rh183-2 GACGGTCAACGGTACGGTGTG 21 3 3 + 191178
miR-Rh225 TCCGGAACGGGAGACATGGAGA 22 58 264 + 216779
a miRNA start sites refer to the 68-1 strain of RhCMV.
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Fig. 2. Genomic organization of RhCMVmiRNAs. The RhCMVmiRNAs are depicted as black arrowswith the corresponding nomenclature above. Right-facing arrows indicatemiRNAs encoded
on the sense strand, while left-pointing arrows indicate miRNAs encoded on the antisense strand. Large gray arrows represent annotated open reading frames as per Hansen et al. (2003).
136 M.H. Hancock et al. / Virology 425 (2012) 133–142expression peaked at the earliest time tested followed by a decline over
the remainder of infection
RhCMV miRNA expression was also examined in endothelial cells
(EC) to determine if the pattern of miRNA expression was similar to
infected ﬁbroblasts. The replication of RhCMV in EC is delayed by ap-
proximately 24–48 h in comparison to ﬁbroblasts as determined by
viral DNA copy number as well as expression of immediate early 2
(IE2) protein (Fig. 4A and data not shown). In addition to the delay
in RhCMV expression, the total quantity of RhCMV DNA was approx-
imately 2.5-fold lower in EC compared to ﬁbroblasts (Fig. 4A). Paral-
leling the decrease in viral DNA, miRNA expression was also lower
in endothelial cells. Unlike the different kinetic patterns of miRNA ex-
pression observed in ﬁbroblasts, all RhCMV miRNAs exhibited an in-
crease in abundance throughout the time-course of infection in
endothelial cells (Fig. 4B).
RhCMV miRNAs are associated with Argonaute 2
Association of a small RNA with the RISC complex is one of the
deﬁning characteristics of a miRNA. Co-immunoprecipitation (Co-
IP) of a viral miRNA with the RISC component Argonaute (Ago)
suggests the formation of a functional miRNA complex during in-
fection. To further elucidate the importance of the RhCMV miRNAs
during infection of ﬁbroblasts we determined whether a subset of
RhCMV miRNAs is enriched in the RISC complex using RISC-IP
(Grey et al., 2010). Cells were infected for 48 h, followed by lysis
and immunoprecipitation using pre-immune sera or an anti-Ago2
rabbit polyclonal antibody developed in our lab which cross-
reacts with rhesus Ago2 (data not shown). RNA isolated from
total RNA and IP samples was analyzed by stem loop RT-PCR for
miR-Rh16 and miR-Rh183-1 as well as the low abundance miR-
NAs miR-Rh70 and miR-Rh225. Additionally, association of the
cellular snRNA U6, which is not associated with the RISC complex
(Riley et al., 2010), was examined. As demonstrated in Fig. 5, each
of the RhCMV miRNAs was enriched in the RISC complex from
190-fold to 1700-fold, while the cellular snRNA U6 showed little
association with Ago2. Therefore, RhCMV miRNAs associate withthe RISC component Ago2, suggesting the formation of RISC com-
plexes containing both high and low abundance viral miRNAs dur-
ing infection of ﬁbroblasts.
RhCMV encodes a homologue of HCMV miR-US5-2
Despite the extensive sequence homology between HCMV and
RhCMV, only one of the RhCMV miRNAs has a potential homologue
in HCMV. Comparison of miR-Rh183-1 and miR-US5-2 sequences in-
dicates that the seed sequence of miR-Rh183-1 is shifted by one nu-
cleotide, leaving six of the core seed nucleotides identical (Fig. 6A).
In addition, eleven other nucleotides outside the seed region are
also identical. miR-US5-2 is encoded antisense to the 3′ UTR of
HCMV US7, while miR-Rh183-1 is encoded antisense to the 3′ UTR
of Rh186 (Fig. 2). Rh186 is a positional homologue of HCMV US7
that is located between Rh185 (US6) and Rh187 (US8) (Pande et al.,
2005). Recently our group has reported that miR-US5-2 down-
regulates expression of HCMV US7 through its 3′ UTR (Tirabassi et
al., 2011). To determine whether miR-Rh183-1 functions similar to
miR-US5-2, the putative 3′ UTRs of both Rh186 and US7 were cloned
into a dual luciferase reporter vector. Transfection of 293 cells with
miR-Rh183-1 and the Rh186 reporter vector or miR-US5-2 and the
US7 reporter vector resulted in down-regulation of luciferase expres-
sion (Fig. 6B). Mutation of the target sequences within the Rh186 and
US7 3′ UTRs resulted in wild-type luciferase activity. Neither miR-
Rh183-1 nor miR-US5-2 was able to downregulate US7 or Rh186 re-
spectively, indicating that the 6 nucleotide match of the seed se-
quence is insufﬁcient to mediate effective down-regulation of the
reciprocal viral genes. Since miR-US5-2 and miR-Rh183-1 are
encoded antisense to the 3′UTR of their target genes, the strong
down-regulation of gene expression is likely mediated by the full 23
nucleotide match.
Expression of RhCMV miRNAs in rhesus macaque tissues
To examine viral miRNAs expression in naturally-infected rhesus
macaques shedding RhCMV, RNA was extracted from persistently
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Fig. 3. Kinetics of RhCMV miRNA expression in ﬁbroblasts. Immortalized rhesus ﬁbroblasts were mock-infected or infected with 2 PFU/cell of RhCMV and RNA was harvested at the
indicated timepoints. Stem-loop RT-PCR was performed using miRNA-speciﬁc primers. Viral miRNA copy numbers were determined using serial dilutions of oligo standards repre-
senting the miRNA sequence. Data was normalized to total RNA and used to determine the relative miRNA copy number per cell. 3 independent experiments are represented as
mean copy number +/− standard deviation.
137M.H. Hancock et al. / Virology 425 (2012) 133–142infected salivary gland tissue of four animals and examined for the
presence of viral miRNAs. The amount of RhCMV in each salivary
gland sample was determined by qPCR and viral DNA was detected
in each animal at copy numbers ranging from approximately
2×104 to 2×105 (Fig. 7A). RhCMV miRNA-speciﬁc stem-loop RT-PCR
assays were used to assess the copy number of each miRNA in 100 ng
of total RNA isolated from homogenized tissue. Using oligonucleotide
standards, this assay can reliably detect as little as 100 copies of
miRNA. Five RhCMV miRNAs were detected in all animals, while a
sixth miRNA was detected in one of four animals (Fig. 7B). RhCMVmiR-Rh16, the most abundant miRNA identiﬁed by NGS, was detected
in all animals, as were miR-Rh96-1 and miR-Rh96-3 (Fig. 7B). The
othermember of this cluster,miR-Rh96-2was not detected above back-
ground levels. miR-Rh70 and miR-Rh225 were also detected in all the
infected animals, while miR-Rh106-1 was detected in only one animal
above background levels (Fig. 7B). Interestingly, two of the most
abundant RhCMV miRNAs detected in ﬁbroblasts, miR-Rh176 and
miR-Rh183-1, were not detected in the salivary gland tissue. These
results suggest that there may be important roles for speciﬁc RhCMV
miRNAs in the salivary gland during persistent infection.
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Fig. 4. RhCMVmiRNA expression in endothelial cells. Rhesus microvascular endothelial cell (RhMVEC) or telomerized rhesus ﬁbroblasts (tRhF) were mock-infected or infected with
2 PFU/cell of RhCMV and DNA and RNAwas harvested at the indicated timepoints. (A) 100 ng of DNA was used to perform Real-time PCR for Rh87. Data is presented as relative copy
number as determined using serial dilution of RhCMV BAC DNA. Data was normalized to cellular β-actin. (B) Experiments were performed as in the legend of Fig. 3.
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Fig. 5. RhCMV miRNAs are enriched in RISC. Rhesus ﬁbroblasts were mock-infected or
infected with 2 PFU/cell of RhCMV for 48 h, after which cells were lysed and immuno-
precipitations were performed using pre-immune sera or an anti-Ago2 antibody. Total
and immunoprecipitated RNA was subjected to stem-loop RT-PCR for RhCMV miRNAs
and the snRNA U6. Fold enrichment of a miRNA in Ago2 complexes was determined by
comparing the IP/Total RNA values from samples immunoprecipitated with the Ago2
antibody to the IP/Total RNA values from samples immunoprecipitated with the pre-
immune sera. Experiments were performed in duplicate.
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In this study, seventeen RhCMV miRNAs were identiﬁed by NGS,
thirteen of which were conﬁrmed during infection of rhesus ﬁbro-
blasts and endothelial cells by miRNA-speciﬁc RT-PCR. A subset of
the RhCMV miRNAs was detected in the salivary glands of persistent-
ly infected rhesus macaques. Unlike HCMV, RhCMV exhibits distinct
kinetic classes of miRNA expression in infected ﬁbroblasts. Addition-
ally, one of the RhCMV miRNAs was a positional and functional ho-
mologue of HCMV miR-US5-2.
Expression patterns for HCMV, MCMV and RCMV miRNAs in
infected ﬁbroblasts all follow a similar trend, with miRNAs increasing
in abundance over the course of infection (Dolken et al., 2007; Grey et
al., 2005;Meyer et al., 2011). In contrast, RhCMVmiRNAs are expressed0
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Fig. 6. RhCMV miR-Rh183-1 is homologous to HCMV miR-US5-2. (A) Sequence align-
ment of miR-Rh183-1 and miR-US5-2. The seed sequence of each miRNA is underlined.
(B) 293 cells were co-transfected with dual luciferase reporters encoding the WT
Rh186 and US7 3′UTRs or reporters with mutations in the miRNA target sites
(Rh186mut and US7mut) as well as miRNA mimics of miR-Rh183-1, miR-US5-2 or a
negative control miRNA. 24 h after transfection, cells were harvested and luciferase activ-
itywasmonitored. Experimentswere performed in triplicate and presented asmean+/−
standard deviation with the negative control set to 1.in three distinct patterns in infected ﬁbroblasts. Five of the RhCMVmiR-
NAs had peak expression at 24–48 hours post-infection and declined
after this time. In addition, miR-Rh106-2 was expressed at the highest
levels at the earliest time sampled, and declined considerably by
48 hours post-infection. Finally, seven of the RhCMV miRNAs increase
in abundance throughout 120 h of infection. Interestingly, Herpes B
virus, a rhesus macaque homolog of herpes simplex virus (HSV), also
displays several different kinetic patterns of miRNA expression during
lytic infection of Vero cells (Amen and Grifﬁths, 2011), while HSV
types 1 and 2 miRNAs accumulate throughout infection (Cui et al.,
2006; Jurak et al., 2010). The different patterns of expression in rhesus
ﬁbroblasts may represent the expression patterns of the viral tran-
scripts fromwhich thesemiRNAs are derived. In support of this hypoth-
esis, RhCMVmiRNAs have decreased abundance and altered expression
patterns in ECs, which could be the result of reduced expression from
the viral genome in this cell type (Fig. 4).
Calculating the approximate copy number of eachmiRNA during in-
fection of ﬁbroblasts identiﬁed three RhCMVmiRNAs (miR-Rh16, miR-
Rh176 andmiR-Rh183-1) that are detected at hundreds to thousands of
copies per cell while the remaining RhCMV miRNAs are much less
abundant (Fig. 3). Nevertheless, the RhCMV miRNAs identiﬁed in this
report were detected by both NGS and RT-PCR, map to hairpin struc-
tures within the RhCMV genome and associate with the RISC compo-
nent Ago2 (Fig. 5). A recent study using NGS also reported low copy
numbers for some HCMV miRNAs (Stark et al., 2012). Factors that con-
tribute to miRNA abundance include the rate of transcript accumula-
tion, the efﬁciency of miRNA processing and the rate of miRNA decay.
miRNA stability can be inﬂuenced by cellular modiﬁcations, Argonaute
protein levels, exposure of the miRNAs to nucleases and target abun-
dance (Kai and Pasquinelli, 2010). The relative contribution of each of
these factors to miRNA abundance during CMV infection has not yet
been assessed. The identiﬁcation of low abundance RhCMV miRNAs
enriched in the RISC complex strongly suggests that these miRNAs
have an important role during viral infection. Additionally, a subset of
the low-abundance miRNAs was speciﬁcally detected in persistently
infected salivary gland tissue, suggesting a signiﬁcant role for these
miRNAs during infection in vivo (Fig. 7). In contrast, miR-Rh176 and
miR-Rh183-1, which both accumulate in high abundance in ﬁbroblasts
and ECs, could not be detected in the infected salivary gland. Thus, it is
possible that some of the RhCMV miRNAs may be more highly
expressed in cell types relevant to viral persistence and/or latency.
The detection of only six of the seventeen RhCMVmiRNAs in salivary
gland tissue from rhesus macaques suggests a dynamic situation in
which only some of the transcripts from the RhCMV genome are
being expressed and/or processed to form mature miRNAs during per-
sistence. Correspondingly, RT-PCR analysis of salivary gland tissue
from RCMV-infected animals demonstrated differential expression of
miR-R87-1 and miR-r111.1-2 during the acute and persistent phases
of infection (Meyer et al., 2011). The speciﬁc miRNAs detected in the
macaque salivary gland may play important roles in maintaining the
viral genome in this tissue, as has been suggested for MCMV miR-
M23-2 and miR-m21-1. Infection of C57BL/6 mice with a miR-M23-2/
m21-1 knockout virus resulted in a 100-fold decrease in virus produc-
tion in the salivary gland (Dolken et al., 2010). This observation
depended upon the mouse strain and viral load used, and was reversed
by the combined depletion of NK and CD4+ T cells, suggesting a com-
plex relationship in vivo between host genetic factors and the viral miR-
NAs which are required to maintain the viral genome.
Despite the signiﬁcant sequence homology between HCMV and
RhCMV, only one miRNA of RhCMV has an HCMV homologue
(Fig. 6). Homologous miRNAs have only rarely been identiﬁed in the
herpesvirus family. Herpes B virus shares no miRNAs in common
with HSV-1 or -2 (Amen and Grifﬁths, 2011). Rhesus rhadinovirus
(RRV) has only one miRNA in common with its human counterpart,
Kaposi's sarcoma-associated herpesvirus (KSHV) (Umbach et al.,
2010), while only 7 of the 68 miRNAs identiﬁed in rhesus
AB
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Fig. 7. RhCMV expression in salivary gland tissue from infected rhesus macaques. (A) 100 ng of DNA was isolated from homogenized salivary gland tissue from four animals per-
sistently infected with RhCMV and one RhCMV-negative animal and subjected to Real-time PCR using primers for Rh87. Relative DNA copy number was determined by serial di-
lution of RhCMV BAC DNA. Data was normalized to cellular β-actin. (B) 100 ng of RNA was isolated from homogenized salivary gland tissue from four RhCMV-infected animals and
one RhCMV-negative animal and subjected to stem-loop RT-PCR. Data was normalized to cellular miR-16 levels. ND — Not detected.
140 M.H. Hancock et al. / Virology 425 (2012) 133–142lymphocryptovirus (rLCV) are closely related to Epstein Barr virus
(EBV) miRNAs (Cai et al., 2006). The similarity between miR-Rh183-
1 and miR-US5-2 suggests signiﬁcant pressure to maintain the seed
sequence during evolution in their respective hosts, indicating that
regulating their viral and cellular targets is of signiﬁcant importance
for viral replication. Our laboratory has recently demonstrated that
genetically removing miR-US5-2 from the HCMV genome results in
an increase in US7 protein expression during infection of ﬁbroblasts
(Tirabassi et al., 2011). US7 is found within a cluster of genes involved
in MHC down-regulation (Tortorella et al., 2000), however the role of
this protein during viral infection is currently unclear. HCMV down-
regulates expression of US7 using three target sites for two viral miR-
NAs (miR-US5-1 and miR-US5-2), while the Rh186 3′ UTR contains
potential target sites for six RhCMVmiRNAs (data not shown), under-
scoring the importance of regulating expression of this protein during
the viral lifecycle. The full panel of viral and cellular targets for miR-
US5-2 and miR-Rh183-1 has yet to be deﬁned; however the conser-
vation of miRNA sequence strongly implies that these miRNAs target
similar genes that are important for viral replication and/or persis-
tence. The rhesus macaquemodel provides a means to test the impor-
tance of the miR-US5-2 homologue in a relevant non-human primate
system.
The species speciﬁcity of CMVs has hampered the identiﬁcation of
miRNAs important in HCMV pathogenesis and persistence. RhCMV
infection of rhesus macaques is a valuable model system for CMV
pathogenesis due to the genetic similarity of the viruses. Here we
both identify the miRNAs encoded by RhCMV and provide a compre-
hensive analysis of their expression kinetics during lytic infection.This knowledge constitutes the basis for identifying cell-type and
tissue-speciﬁc targets of the viral miRNAs. Given that at least one
miRNA has a partially conserved seed sequence between HCMV and
RhCMV, relevant questions regarding the importance of identiﬁed
targets can be addressed in an in vivomodel system of CMV infection.
In addition, RhCMV and HCMV miRNAs may target similar genes or
pathways using different miRNAs to achieve downregulation of target
expression. This is a readily testable hypothesis in our model system
now that the sequences of the RhCMV miRNAs have been identiﬁed.
Materials and methods
Cells, tissue and virus
Rhesus ﬁbroblasts that were life-extended with telomerase were a
gift from Dr Scott Wong and were maintained in Dulbecco's modiﬁed
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum
(FBS; Hyclone), 100U/mL of penicillin and 100ug/mL of streptomycin
(Invitrogen). Primary rhesus brain microvascular endothelial cells
were a gift from Dr Ashlee Moses and were maintained in endothelial
cell basal medium supplemented with EGM-MV SingleQuots (Lonza).
293 cells were obtained from the American Type Culture Collection
and maintained in DMEM as stated above. Cells were infected with
RhCMV strain 68-1 at a multiplicity of 2 plaque forming units
(PFU)/cell for 2 h at 37 °C. After this time, the inoculum was removed
and replaced with fresh medium. Cells were harvested at various
times post-infection using DNAzol or Trizol (Invitrogen) as appropri-
ate. Samples were stored at 4 °C (DNAzol) or−80 °C (Trizol) prior to
141M.H. Hancock et al. / Virology 425 (2012) 133–142analysis. Rhesus macaque tissues were obtained from the Oregon Na-
tional Primate Research Center and stored at −80 °C immediately
after necropsy. ~0.5 g of tissue was suspended in Trizol or DNAzol
and homogenized using glass beads.
miRNA deep sequencing
Next generation sequencing was performed by LC Sciences
(Houston, TX). Brieﬂy, total RNA was size-fractionated on a 15% tris-
borate-EDTA-Urea (TBE) polyacrylamide gel. RNA fragments 15-50
nucleotides were eluted from the gel and ethanol precipitated. 5′
and 3′ adapters (Illumina) were ligated using T4 RNA ligase (Pro-
mega) and size-fractionated on 15% TBE polyacrylamide gels, followed
by gel elution and ethanol precipitation. Next, cDNAwas reverse tran-
scribed usingM-MLV (Invitrogen) and Illumina RT primers and ampli-
ﬁed for 20 cycles with PFX DNA polymerase and the Illumina small
RNA primer sets. These cDNAs were then puriﬁed on a 12% TBE poly-
acrylamide gel and a slice ~80–115 bp was excised. cDNAs were elut-
ed, ethanol precipitated and resuspended for deep sequencing using
Illumina's GAIIx sequencer following the vendor's instructions. Raw
sequencing data was ﬁltered for composition, adapter dimers, length,
sequence composition and copy number. The ﬁltered data was
mapped to miRBase, the Macaca mulatta genome and the RhCMV ge-
nome and stable hairpin structures were determined.
qPCR detection of RhCMV miRNAs
RT-PCRwas used to quantitate the amount of viral DNA ormiRNA in
infected rhesus ﬁbroblasts, endothelial cells and salivary gland tissue.
Total RNA was isolated from infected cells or tissue using Trizol. cDNA
was prepared using 100 ng of total RNA and miRNA-speciﬁc stem-
loop RT primers designed to the most abundant species detected by
NGS for each miRNA (see Table 1). Samples were incubated at 16 °C
for 30 min, 42 °C for 30 min and 85 °C for 5 min. Real-time PCR (Taq-
man) was used to quantify the miRNA copy number from 10 ng of the
cDNA reaction. An ABI StepOnePlus Real Time PCR machine was used
with the following program for 40 cycles: 95 °C for 15 s and 60 °C for
1 min. Forward primers and probes are outlined in Table 1. The same re-
verse primer (GTGCAGGGTCCGAGGT)was used in all assays. Standards
were designed as oligonucleotides with the same sequence as the
miRNA of interest and data is presented as relative copy number per
cell. To determine relative copy number of each miRNA per cell,
miRNA copy number was ﬁrst determined in 10 ng of total RNA using
a known concentration of oligo standards. This value was multiplied
by the total amount of RNA isolated from the infected cells and then di-
vided by the total number of cells as determined prior to infection. Each
experiment was performed in triplicate. This assay can detect as few as
100 copies of miRNA in 10 ng of total RNA as determined using the oli-
gonucleotide standards. For miRNA detection in persistently infected
salivary gland tissue, miRNA copy numbers were normalized to the ex-
pression of cellular miR-16, detected using the miR-16 Taqman miRNA
assay (Applied Biosystems). Expression of miR-16 was not affected by
RhCMV during infection of ﬁbroblasts (data not shown).100 ng of
viral DNA isolated using DNAzol was used in the Real-time PCR reac-
tions. Rh87 Forward primer: GCGCCACAAACGTGGAATAACAGA Reverse
primer: TACAGTGATCCCGTGGTGGTGTTT Probe: ATTGACGGATA-
CAGGCTGGCAAAGTC. Relative copy number was calculated using a se-
rial dilution of BAC DNA and normalized to cellular β-actin. β-actin
Forward primer: TCACCCACACTGTGCCCATCTACGA Reverse primer:
CAGCGGAACCGCTCGTTGCCAATGG
RISC immunoprecipitation
RISC IPs were carried out as previously described (Grey et al.,
2010). Rhesus ﬁbroblasts were mock infected or infected with 2
PFU/cell of RhCMV for 48 h. Cells were lysed and samples weretaken for total RNA levels. miRNP complexes were immunoprecipi-
tated using rabbit anti-Ago2 antibody or pre-immune sera and pro-
tein A sepharose beads (Sigma). RNA was isolated using Trizol and
stem loop RT-PCR was performed as described above. Fold enrich-
ment was calculated as IP/Total RNA from samples immunoprecipi-
tated with the Ago2 antibody compared to IP/Total RNA from
samples immunoprecipitated using the pre-immune sera. The U6
RT-PCR assay was obtained from Applied Biosystems.
Dual luciferase assay
The putative 3′ UTRs of RhCMV Rh186 and HCMV US7 were cloned
into the dual luciferase reporter pSiCheck2 (Clontech). Site-directed
mutagenesis was performed to mutate the single miR-Rh183-1 bind-
ing site in the Rh186 3′UTR and both miR-US5-2 binding sites in US7
3′UTR to produce Rh186mut and US7mut. 293 cells seeded into 96-
well plates were co-transfected in triplicate with 100 ng of plasmid
and 100 fmol of miRNA mimic (custom designed; IDT) using Lipofec-
tamine 2000. Cells were incubated overnight, and then harvested for
luciferase assay using the Dual-Glo Reporter Assay Kit (Promega)
according to the manufacturer's protocol. Luminescence was detected
using a Veritas Microplate Luminometer (Turner Biosystems). All ex-
periments were performed in triplicate and presented as mean +/−
standard deviation.
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